Donation

The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.

Order Print Edition

 

Full of our informative publications, including our Patient Handbook and selections from the popular Understanding Series, the Info Pack will…

This publication discusses the use of Velcade (bortezomib)—a proteasome inhibitor—for the treatment of myeloma.
This booklet discusses dexamethasone, a synthetic steroid that is one of the most frequently used medica­tions in the treatment of myeloma. It can be…
This publication discusses the use of Ninlaro (ixazomib)—a proteasome inhibitor—for the treatment of myeloma.

Carvykti™ (ciltacabtagene autoleucel, or “cilta-cel” for short) is a customized immunotherapy approved by the FDA for the treatment of adult…

We Thank Our Sponsors:
BMS, Janssen, Karyopharm Therapeutics, Legend Biotech, and Takeda Pharmaceuticals U.S.A., Inc.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.